Atlas Trials

RHEACELL GmbH & Co. KG

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch RHEACELL GmbH & Co. KG

RecordFirmDate
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III) (NCT06489028)RHEACELL GmbH & Co. KG2024-12-26
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III) (NCT05838092)RHEACELL GmbH & Co. KG2023-10-18
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over) (NCT05464381)RHEACELL GmbH & Co. KG2023-06-13
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb) (NCT04971161)RHEACELL GmbH & Co. KG2021-08-18
Allogeneic ABCB5-positive Limbal Stem Cells for Treatment of LSCD (NCT03549299)RHEACELL GmbH & Co. KG2019-07-04
Allogeneic ABCB5-positive Stem Cells for Treatment of Acute-on-Chronic Liver Failure (NCT03860155)RHEACELL GmbH & Co. KG2019-03-22
Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa (NCT03529877)RHEACELL GmbH & Co. KG2019-02-16
Allogeneic ABCB5-positive Stem Cells for Treatment of PAOD (NCT03339973)RHEACELL GmbH & Co. KG2018-03-05
Allogeneic ABCB5-positive Stem Cells for Treatment of DFU "Malum Perforans" (NCT03267784)RHEACELL GmbH & Co. KG2017-11-21
Allogeneic ABCB5-positive Stem Cells for Treatment of CVU (NCT03257098)RHEACELL GmbH & Co. KG2017-11-16

Track RHEACELL GmbH & Co. KG automatically

Every clearance here is in the API, with alerts when new ones post.